Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 23.4B | 23.9B | 24.4B | 25.0B |
| Cost of revenue | 18.4B | 18.1B | 19.1B | 19.7B |
| Gross profit | 4.9B | 5.8B | 5.3B | 5.3B |
| Operating expense | ||||
| Research & development | 808M | 773M | 745M | 780M |
| Selling general and admin | 3.0B | 2.7B | 2.9B | 3.2B |
| Other operating expenses | — | — | — | — |
| Operating income | 1.2B | 2.3B | 1.7B | 1.3B |
| Non operating interest income | ||||
| Income | 31M | 33M | 35M | 42M |
| Expense | 361M | 344M | 328M | 387M |
| Other income expense | 248M | 124M | 17M | -8M |
| Pretax income | 1.1B | 2.1B | 1.4B | 989M |
| Tax provision | 118M | 467M | 265M | 148M |
| Net income | 965M | 1.7B | 1.1B | 841M |
| Basic EPS | 1.4 | 2.2 | 1.6 | 1.2 |
| Diluted EPS | 1.4 | 2.2 | 1.6 | 1.2 |
| Basic average shares | 692M | 696.1M | 703M | 708M |
| Diluted average shares | 702M | 713.0M | 717M | 724M |
| EBITDA | 1.9B | 3.1B | 2.5B | 2.2B |
| Net income from continuing op. | 965M | 1.7B | 1.1B | 804M |
| Minority interests | 0 | 1M | 5M | 5M |
| Preferred stock dividends | — | — | — | — |